Psychopathological And Cognitive Effects Of Therapeutic Cannabinoids In Multiple Sclerosis: A Double-blind, Placebo Controlled, Crossover Study

Multiple Sclerosis (MS)

Key Findings

Within therapeutic doses, no impairment or negative psychological symptoms noted. However, at high dosages, negative psychological symptoms noted.

Information and Links


Link: Psychopathological And Cognitive Effects Of Therapeutic Cannabinoids In Multiple Sclerosis: A Double-blind, Placebo Controlled, Crossover Study

Year: 2009

DOI: 10.1097/WNF.0B013E3181633497


Ratings

(How Ratings Work)

Multiple Sclerosis (MS) — 5


Demonstrable efficacy of cannabis for treatment of Multiple Sclerosis (MS) according to the results found in this study.

Drugs Used

Free-dose cannabis plant extract (Sativex)